DRTS

$0.00

(

0.00%

)
Quote details

stock

Alpha Tau Medical Ltd

NASDAQ | DRTS

3.84

USD

$0.00

(

0.00%

)

At Close (As of Sep 17, 2025)

$328.28M

Market Cap

-

P/E Ratio

-0.48

EPS

$4.38

52 Week High

$2.11

52 Week Low

HEALTHCARE

Sector

DRTS Chart

Recent Chart
Price Action

DRTS Technicals

Tags:

DRTS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$1.1M
Total Revenue $0
Cost Of Revenue $1.1M
Costof Goods And Services Sold $1.1M
Operating Income -$36M
Selling General And Administrative $6.7M
Research And Development $27M
Operating Expenses $35M
Investment Income Net -
Net Interest Income $3.9M
Interest Income $4.3M
Interest Expense $344K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.1M
Income Before Tax -$32M
Income Tax Expense $6K
Interest And Debt Expense -
Net Income From Continuing Operations -$32M
Comprehensive Income Net Of Tax -
Ebit -$31M
Ebitda -$30M
Net Income -$32M

Revenue & Profitability

Earnings Performance

DRTS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $86M
Total Current Assets $64M
Cash And Cash Equivalents At Carrying Value $14M
Cash And Short Term Investments $14M
Inventory -
Current Net Receivables $332K
Total Non Current Assets $22M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $46M
Other Current Assets $4.3M
Other Non Current Assets -
Total Liabilities $24M
Total Current Liabilities $8.7M
Current Accounts Payable $3.5M
Deferred Revenue -
Current Debt -
Short Term Debt $2M
Total Non Current Liabilities $15M
Capital Lease Obligations $7M
Long Term Debt $5.6M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $13M
Other Current Liabilities $3.1M
Other Non Current Liabilities -
Total Shareholder Equity $63M
Treasury Stock -
Retained Earnings -$148M
Common Stock -
Common Stock Shares Outstanding $70M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$20M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.1M
Capital Expenditures $2.2M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $21M
Cashflow From Financing $25K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$32M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$1.1M
Total Revenue $0
Cost Of Revenue $1.1M
Costof Goods And Services Sold $1.1M
Operating Income -$36M
Selling General And Administrative $6.7M
Research And Development $27M
Operating Expenses $35M
Investment Income Net -
Net Interest Income $3.9M
Interest Income $4.3M
Interest Expense $344K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.1M
Income Before Tax -$32M
Income Tax Expense $6K
Interest And Debt Expense -
Net Income From Continuing Operations -$32M
Comprehensive Income Net Of Tax -
Ebit -$31M
Ebitda -$30M
Net Income -$32M

DRTS News

DRTS Profile

Alpha Tau Medical Ltd Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Alpha Tau Medical Ltd. (Ticker: DRTS) is a clinical-stage oncology company specializing in the innovative development and commercialization of its proprietary alpha-emitting radiation therapy, Alpha DaRT, which targets solid tumors. Headquartered in Jerusalem, Israel, the company aims to revolutionize cancer treatment by offering a novel therapeutic approach that minimizes harm to surrounding healthy tissue while maximizing tumor ablation. With key operations in both Israel and the United States, Alpha Tau is positioned to make significant strides in the oncology field, addressing unmet medical needs for patients with difficult-to-treat cancers.

ATCH
+87.36%
$1.62
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
NFE
+8.00%
$2.16
QBTS
+18.75%
$22.54
NIO
+6.12%
$7.45
SPRC
+142.93%
$4.47
GRAB
-3.48%
$6.10
AAL
+0.56%
$12.48
TSLA
+1.00%
$425.86
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NUAI
-4.00%
$0.45
NEHC
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
RGTI
+9.94%
$21.99
SOFI
-1.02%
$27.14
TPIC
-45.91%
$0.12
ADAP
-1.22%
$0.08
PLTR
-1.13%
$168.33
F
+0.43%
$11.66
DNN
+1.60%
$2.54
AXDX
-61.36%
$0.03
BBD
+3.11%
$3.31
BMNR
+2.03%
$57.07
INTC
-1.46%
$24.90
PGRE
-11.63%
$6.53
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
JOBY
-1.59%
$14.16
MULN
-12.58%
$0.06
KDLY
-4.66%
$1.43
NAKA
-4.66%
$1.43
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
IONQ
+5.10%
$65.44
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.98%
$92.95
RIOT
+0.57%
$17.62
AMZN
-1.03%
$231.62
ACHR
-1.20%
$9.00
AIRE
-1.57%
$1.25
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
ABEV
0.00%
$2.36
LDI
+2.70%
$4.55
BINI
-6.96%
$0.06
RMBL
+60.50%
$3.21
WULF
+3.74%
$11.35
OPI
-31.80%
$0.56
BAC
+1.46%
$51.40
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
HOOD
+1.07%
$118.64
DVLT
-22.98%
$0.34
NOK
+1.84%
$4.69
QUBT
+4.97%
$17.71
CIFR
+7.55%
$12.38
GOOGL
-0.64%
$249.53
IREN
+3.97%
$37.90
ATYR
-5.09%
$1.02
INFY
+3.63%
$17.68
CWD
+19.05%
$7.56
JD
+1.52%
$35.24
GPUS
+6.65%
$0.41
FAAS
-6.04%
$0.09
ITUB
+1.82%
$7.27
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BABA
+2.44%
$166.17
KEY
+0.42%
$18.71
BTE
-2.49%
$2.54
NVTS
+9.67%
$6.46
IONZ
-10.28%
$4.80
WLGS
-5.57%
$0.04
RXRX
-2.68%
$4.71
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
HBAN
+0.63%
$17.54
JBLU
0.00%
$5.07
GDXD
+1.63%
$1.24
RAYA
-4.69%
$0.04
HIMS
-1.06%
$50.35
ATCH
+87.36%
$1.62
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
NFE
+8.00%
$2.16
QBTS
+18.75%
$22.54
NIO
+6.12%
$7.45
SPRC
+142.93%
$4.47
GRAB
-3.48%
$6.10
AAL
+0.56%
$12.48
TSLA
+1.00%
$425.86
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NUAI
-4.00%
$0.45
NEHC
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
RGTI
+9.94%
$21.99
SOFI
-1.02%
$27.14
TPIC
-45.91%
$0.12
ADAP
-1.22%
$0.08
PLTR
-1.13%
$168.33
F
+0.43%
$11.66
DNN
+1.60%
$2.54
AXDX
-61.36%
$0.03
BBD
+3.11%
$3.31
BMNR
+2.03%
$57.07
INTC
-1.46%
$24.90
PGRE
-11.63%
$6.53
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
JOBY
-1.59%
$14.16
MULN
-12.58%
$0.06
KDLY
-4.66%
$1.43
NAKA
-4.66%
$1.43
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
IONQ
+5.10%
$65.44
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.98%
$92.95
RIOT
+0.57%
$17.62
AMZN
-1.03%
$231.62
ACHR
-1.20%
$9.00
AIRE
-1.57%
$1.25
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
ABEV
0.00%
$2.36
LDI
+2.70%
$4.55
BINI
-6.96%
$0.06
RMBL
+60.50%
$3.21
WULF
+3.74%
$11.35
OPI
-31.80%
$0.56
BAC
+1.46%
$51.40
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
HOOD
+1.07%
$118.64
DVLT
-22.98%
$0.34
NOK
+1.84%
$4.69
QUBT
+4.97%
$17.71
CIFR
+7.55%
$12.38
GOOGL
-0.64%
$249.53
IREN
+3.97%
$37.90
ATYR
-5.09%
$1.02
INFY
+3.63%
$17.68
CWD
+19.05%
$7.56
JD
+1.52%
$35.24
GPUS
+6.65%
$0.41
FAAS
-6.04%
$0.09
ITUB
+1.82%
$7.27
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BABA
+2.44%
$166.17
KEY
+0.42%
$18.71
BTE
-2.49%
$2.54
NVTS
+9.67%
$6.46
IONZ
-10.28%
$4.80
WLGS
-5.57%
$0.04
RXRX
-2.68%
$4.71
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
HBAN
+0.63%
$17.54
JBLU
0.00%
$5.07
GDXD
+1.63%
$1.24
RAYA
-4.69%
$0.04
HIMS
-1.06%
$50.35

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.